Wake Forest University Health Sciences
In order to formulate strategies to improve adherence to best practice guidelines, as well as utilization of novel therapies, investigators must understand current practice patterns surrounding tumor genetic testing in endometrial cancer. The aim is to survey a representative sample of gynecologic oncologists who belong to the society of gynecologic oncology, via an email survey, to better understand current practices surrounding tumor genetic testing as well as determine if there have been any changes to practice since the publication of recent trials on the use of immune-checkpoint inhibitors in endometrial cancer.
Endometrial Cancer
Surveys
Primary Objective: Proportion of physicians reporting the use of different tumor genetic testing strategies among newly diagnosed endometrial cancer patients. Secondary Objectives: * Explore the use of informed consent in tumor genetic testing in endometrial cancer * Explore clinician confidence in utilizing tumor genetic testing to guide treatment decisions. * Explore the impact of recent publications regarding immunotherapy on the use of tumor genetic testing in endometrial cancer.
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 112 participants |
| Official Title : | Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial Cancer |
| Actual Study Start Date : | 2023-08-15 |
| Estimated Primary Completion Date : | 2024-02-28 |
| Estimated Study Completion Date : | 2024-02-28 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: | 1 |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, United States, 27157